Skip to main content
. Author manuscript; available in PMC: 2015 Nov 6.
Published in final edited form as: J Nerv Ment Dis. 2014 Jan;202(1):18–24. doi: 10.1097/NMD.0000000000000065

TABLE 1.

Patient Characteristics at the Time of Random Assignment by Initial Treatment for the Randomization That Excluded Patients With TD or Those Assigned to Ziprasidone

Total Sample Olanzapine Perphenazine Quetiapine Risperidone





Mean/n %/SD Mean/n %/SD Mean/n %/SD Mean/n %/SD Mean/n %/SD










n = 1049 n = 263 n = 256 n = 261 n = 269 χ2/F df p
Age 39.3 10.9% 39.36 10.56 39.97 11.06 39.15 10.88 38.78 11.05 0.55 3 0.65
Male 777 74.0% 190 72.2% 196 76.6% 196 73.5% 199 74.0% 1.3 3 0.72
Race/ethnicity
  White 631 60.1% 153 58.2% 151 59.0% 1.67 64.0% 160 59.5% 2.22 3 0.52
  Black 368 35.1% 96 36.5% 90 35.1% 84 32.1% 98 36.4% 1.4 3 0.70
  Other 50 4.8% 14 5.3% 15 5.9% 10 3.8% 11 4.1% 1.62 3 0.65
  Hispanic 129 12.3% 37 14.1% 24 9.3% 39 14.9% 29 10.8% 5.05 3 0.17
Marital status 16.7 12 0.16
  Married 131 12.5% 30 11.4% 43 16.8% 27 10.3% 31 11.5%
  Separated/divorced 219 20.8% 61 23.2% 50 19.4% 55 20.9% 53 19.8%
  Never married 636 60.6% 159 60.4% 146 57.0% 167 64.0% 164 61.0%
  Widowed
PANSS total 75.5 17.5 75.7 18.2 74.2 18.0 74.8 17.0 77.2 16.5 1.48 3 0.21
  Positive 18.4 5.6 18.4 5.5 17.9 5.9 18.3 5.4 19.0 5.6 1.8 3 0.15
  Negative 20.2 6.5 20.3 6.7 20.3 6.3 19.8 6.5 20.4 6.4 0.43 3 0.72
  General 36.9 9.3 37.0 9.8 36.0 9.5 36.7 9.2 37.8 8.6 1.68 3 0.17
Depression (Cagary Scale) 1.6 0.6 1.6 0.6 1.6 0.6 1.6 0.6 1.6 0.6 0.84 3 0.47
Current comorbidity
  Alcohol abuse/dependence 86 8.2% 20 7.6% 27 10.5% 21 8.0% 18 6.7% 2.83 3 0.41
  Drug abuse/dependence 126 11.9% 30 11.3% 39 15.2% 23 8.8% 34 12.6% 5.31 3 0.15
  Major depression 114 10.8% 25 9.4% 29 11.3% 23 8.8% 37 13.7% 4.08 3 0.25
  Obsessive-compulsive disorder 57 5.4% 8 3.0% 11 4.3% 20 7.7% 18 6.7% 6.9 3 0.07
Side effects    3
  EPS mean (Simpson Agua) 0.18 0.29 0.16 0.27 0.19 0.32 0.16 0.25 0.20 0.29 1.35 3 0.26
  Barnes Akathesia Scale 0.47 0.84 0.58 0.97 0.43 0.79 0.46 0.76 0.47 0.81 2.17 3 0.09
  AIMS Severity Score (TD) 0.12 0.27 0.15 0.31 0.12 0.27 0.11 0.24 0.12 0.23 1.13 3 0.34
  TD (>1 on AIMS Severity) 7 67.0% 1 0.4% 3 1.2% 2 0.8% 1 0.4% 1.7 3 0.63
Quality of Life Scale 2.7 1.1 2.7 1.1 2.7 1.1 2.7 1.1 2.6 1.0 0.73 3 0.53
  Social interaction 2.6 1.3 2.5 1.2 2.6 1.4 2.6 1.4 2.5 1.3 1.21 3 0.30
  Instrumental activity 2.0 1.6 2.0 1.7 2.0 1.6 2.0 1.7 1.9 1.5 0.19 3 0.91
  Intrapsychic activity 3.0 1.2 3.1 1.2 3.0 1.2 3.1 1.2 2.9 1.0 1.35 3 0.26
Lehman Quality of Life Interview 4.3 1.4 4.4 1.4 4.4 1.3 4.4 1.4 4.2 1.5 0.83 3 0.47
Quality-adjusted life-years 0.686 0.126 0.682 0.132 0.689 0.120 0.695 0.123 0.676 0.127 1.11 3 0.34
Patient weighted health index −0.94 3.64 −1.12 3.98 −0.75 3.67 −0.59 3.43 −1.29 3.41 1.86 3 0.13
Body mass index 29.80 7.09 29.24 6.86 29.63 6.93 30.22 7.05 30.09 7.48 1.04 3 0.37
Health costs (previous month)
  All medication $422 $325 $419 $344 $420 $314 $418 $331 $433 $313 0.14 3 0.94
  Inpatient residential/nursing home $1512 $3715 $1828 $3988 $1127 $2530 $1442 $3642 $1636 $4381 1.68 3 0.17
  Outpatient $365 $935 $379 $864 $392 $1173 $410 $1066 $281 $513 1.02 3 0.38
  Total $2299 $3831 $2628 $4078 $1940 $2811 $2271 $3813 $2352 $4398 1.42 3 0.23

AIMS indicates abnormal involuntary movement scale; EPS, extrapyramidal syndrome; TD, tardive dyskinesia.